Hyundai ADM Bio Past Earnings Performance
Past criteria checks 0/6
Hyundai ADM Bio's earnings have been declining at an average annual rate of -90.8%, while the Life Sciences industry saw earnings growing at 31.2% annually. Revenues have been declining at an average rate of 1.4% per year.
Key information
-90.8%
Earnings growth rate
-90.8%
EPS growth rate
| Life Sciences Industry Growth | 53.7% |
| Revenue growth rate | -1.4% |
| Return on equity | -127.4% |
| Net Margin | -137.3% |
| Last Earnings Update | 30 Jun 2024 |
Revenue & Expenses Breakdown
How Hyundai ADM Bio makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 11,561 | -15,872 | 4,509 | 10,118 |
| 31 Mar 24 | 13,116 | -3,801 | 4,464 | 1,113 |
| 31 Dec 23 | 13,790 | -2,970 | 4,490 | 1,064 |
| 30 Sep 23 | 14,557 | -2,086 | 4,369 | 1,038 |
| 30 Jun 23 | 15,320 | -1,294 | 4,158 | 857 |
| 31 Mar 23 | 15,096 | -493 | 4,059 | 721 |
| 31 Dec 22 | 14,883 | 267 | 3,804 | 587 |
| 30 Sep 22 | 15,375 | 1,149 | 3,770 | 535 |
| 30 Jun 22 | 14,374 | 963 | 4,217 | 556 |
| 31 Mar 22 | 14,005 | 1,418 | 4,174 | 544 |
| 31 Dec 21 | 13,978 | 1,923 | 4,072 | 628 |
| 30 Sep 21 | 13,415 | 2,923 | 3,896 | 616 |
| 30 Jun 21 | 13,199 | 3,504 | 3,240 | 803 |
| 31 Mar 21 | 13,049 | 3,564 | 2,919 | 756 |
| 31 Dec 20 | 13,120 | 3,775 | 2,836 | 728 |
| 31 Dec 19 | 10,206 | 764 | 2,160 | 680 |
Quality Earnings: A187660 is currently unprofitable.
Growing Profit Margin: A187660 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A187660 is unprofitable, and losses have increased over the past 5 years at a rate of 90.8% per year.
Accelerating Growth: Unable to compare A187660's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: A187660 is unprofitable, making it difficult to compare its past year earnings growth to the Life Sciences industry (18%).
Return on Equity
High ROE: A187660 has a negative Return on Equity (-127.39%), as it is currently unprofitable.